Neurocrine Bio. (NBIX) PT Lowered to $158 at Canaccord Genuity
Tweet Send to a Friend
(Updated - April 28, 2025 7:18 AM EDT)
Canaccord Genuity analyst Sumant Kulkarni lowered the price target on Neurocrine ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord Genuity analyst Sumant Kulkarni lowered the price target on Neurocrine ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
